The experiment study of DMOG on the survival of cross-boundary flap via tail vein injection in rats
	    		
		   		
		   			
		   		
	    	
    	 
    	10.3760/cma.j.issn.1001-2036.2016.02.010
   		
        
        	
        		- VernacularTitle:尾静脉注射DMOG对大鼠跨区皮瓣choke血管区的影响
 
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Shanshan XI
			        		
			        		;
		        		
		        		
		        		
			        		Maochao DING
			        		
			        		;
		        		
		        		
		        		
			        		Jun ZHENG
			        		
			        		;
		        		
		        		
		        		
			        		Xiaolin LIU
			        		
			        		;
		        		
		        		
		        		
			        		Yihua MAO
			        		
			        		;
		        		
		        		
		        		
			        		Jin MEI
			        		
			        		;
		        		
		        		
		        		
			        		Maolin TANG
			        		
			        		
		        		
		        		
		        		
		        		
		        		
			        		
			        		
		        		
	        		
        		 
        	
        	
        	
        		- Publication Type:Journal Article
 
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		Dimethyloxalylglycine;
			        		
			        		
			        		
				        		Choke vessels;
			        		
			        		
			        		
				        		Cross-boundary flap;
			        		
			        		
			        		
				        		Perforator flap;
			        		
			        		
			        		
				        		Hemodynamics
			        		
			        		
	        			
        			
        		
 
        	
            
            
            	- From:
	            		
	            			Chinese Journal of Microsurgery
	            		
	            		 2016;39(2):143-147
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	Objective To investigate the effects of DMOG on the microcirculation of the choke-area and the survival of the cross-boundary flap in rats via tail vein injection.Methods Rats with ischemic three-territory perforator flaps on the dorsum were treated with DMOG at a dosage of 40 mg/kg body weight via tail vein injection at 1 day before surgery(day-1),the time of surgery(day 0),1 day after surgery(day 1),2 days after surgery(day 2) and 3 days after surgery(day 3).Control group received sterile saline at the same time points and same dosage via tail vein injection.① Draw materials from the choke-area at day 1,day 3 and day 7,HE stain was used to compare the diameter size of the artery and vein at the same site.② Western blotting to check the expression of PCNA and HIF-1α,ELISA to detect the content of PCNA,HIF-1α,SDF-1α and VEGF at day 7.③At day 7,measure the survival area of the flap and observe the vessel of the flap by lead oxide-gelatine technique.Results ① There was a greater survival rate of (96.3 ± 5.1)% in the treatment group than in the control group with (73.9 ± 5.8)% at day 7 (P < 0.05).② The diameter size of the arterioles and venules were dilated in both groups until postoperative days 7.But the treatment group was more expanded than the control group at day 3(2.20 ± 0.26 vs.1.50 ± 0.20,P < 0.05) and day 7(3.67 ± 0.35 vs.2.03 ± 0.15,P < 0.05).③ The skin expression of PCNA and HIF-1α in the treatment group were greater than the control group(P < 0.05) at day 7.④ The content of skin PCNA in the treatment group and control group were(8.95 ± 0.71) ng/mg and (4.15 ± 0.72) ng/mg,HIF-1α were(5.04 ± 0.50)ng/mg and (2.98 ± 0.29) ng/mg,SDF-1α were (2.91 ± 0.61) ng/mg and (1.39 ± 0.62) ng/mg,and VEGF were(2.17 ± 0.41) ng/mg and (0.95 ± 0.44) ng/mg,respectively.The treatment group was greater than the control group (P < 0.05).Conclusion DMOG can improve the microcirculation of the choke area,and then increase the survival of the perforator skin flaps in rats via tail vein injection.